Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9492149rdf:typepubmed:Citationlld:pubmed
pubmed-article:9492149lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C0549473lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C0063695lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C0033634lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:9492149lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:9492149pubmed:issue1lld:pubmed
pubmed-article:9492149pubmed:dateCreated1998-4-2lld:pubmed
pubmed-article:9492149pubmed:abstractTextNonantigen specific adhesion systems lymphocyte function-associated antigen 1/intercellular adhesion molecule (LFA-1/ICAM-1) and cluster designation 2/lymphocyte function-associated antigen 3 (CD2/LFA-3) are considered a crucial step in immune-mediated cell-cell adhesion reactions. In particular, the LFA-1/ICAM-1 system is deeply involved in major histocompatibility system (MHC)-restricted and non-MHC-restricted cellular cytotoxicity of effector cells against cancer tissues. We have investigated in human thyroid carcinoma cell lines the role of the protein kinase C (PKC) pathway on ICAM-1 expression. Incubation with tissue plasminogen activator (TPA), an agonist of PKC, of two papillary (NPA and TPC-1) and one anaplastic (ARO) carcinoma cell lines induced an ICAM-1 upregulation of both protein and mRNA production. This phenomenon was dependent on RNA and protein synthesis and was inhibited by PKC antagonists such as staurosporine and H-7. A parallel increase in the soluble form of ICAM-1 followed the upregulation of cellular ICAM-1 levels induced by TPA. In conclusion, the PKC pathway is involved in the regulation of ICAM-1 expression in human thyroid carcinoma cell lines. Further studies are necessary to clarify the effects of the PKC pathway on the diffusion of thyroid tumors.lld:pubmed
pubmed-article:9492149pubmed:languageenglld:pubmed
pubmed-article:9492149pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:citationSubsetIMlld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9492149pubmed:statusMEDLINElld:pubmed
pubmed-article:9492149pubmed:monthJanlld:pubmed
pubmed-article:9492149pubmed:issn1050-7256lld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:RossiGGlld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:FenziG FGFlld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:BassoLLlld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:FelicielloAAlld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:AltomonteMMlld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:AllevatoGGlld:pubmed
pubmed-article:9492149pubmed:authorpubmed-author:De RiuSSlld:pubmed
pubmed-article:9492149pubmed:issnTypePrintlld:pubmed
pubmed-article:9492149pubmed:volume8lld:pubmed
pubmed-article:9492149pubmed:ownerNLMlld:pubmed
pubmed-article:9492149pubmed:authorsCompleteYlld:pubmed
pubmed-article:9492149pubmed:pagination23-8lld:pubmed
pubmed-article:9492149pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:meshHeadingpubmed-meshheading:9492149-...lld:pubmed
pubmed-article:9492149pubmed:year1998lld:pubmed
pubmed-article:9492149pubmed:articleTitleIntercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell lines.lld:pubmed
pubmed-article:9492149pubmed:affiliationDipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università degli Studi di Napoli "Federico II", Facoltà di Medicina e Chirurgia, Naples, Italy.lld:pubmed
pubmed-article:9492149pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9492149pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9492149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9492149lld:pubmed